Aminooxyphenylpropionate

Aminooxyphenylpropionate

SCHEMBL6513696

NO[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SRR Q9GZT4 4/20 1.00
PSAT1 Q9Y617 2/20 0.80
PPARG P37231 14/20 0.57
PPARA Q07869 12/20 0.57
ALPI P09923 1/20 0.57
PKM P14618 1/20 0.57
PTGS1 P23219 1/20 0.57
XIAP P98170 1/20 0.57
SLC7A5 Q01650 1/20 0.57
ACE P12821 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminooxyphenylpropionate SCHEMBL1401589 1.00 SRR (1.00) SRRPSAT1PPARGPPARAALPI
Aminooxyphenylpropionate SCHEMBL1520985 1.00 SRR (1.00) SRRPSAT1PPARGPPARAALPI
Aminooxyphenylpropionate SCHEMBL1357763 0.98 SRR (0.96) SRRPSAT1PPARGPPARAALPI
SCHEMBL15446238 0.89 SRR (1.00) SRRPSAT1PPARGPPARA
SCHEMBL15446229 0.86 SRR (0.75) SRRPSAT1PPARGPPARA
SCHEMBL288435 0.86 PPARA (0.74) SRRPSAT1PPARGPPARA
SCHEMBL11298237 0.85 SRR (0.73) SRRPSAT1PPARGPPARASLC7A5
SCHEMBL15446294 0.83 SRR (0.71) SRRPSAT1PPARGPPARA
SCHEMBL15446243 0.83 SRR (0.71) SRRPSAT1PPARGPPARA
Bromide SCHEMBL11297122 0.83 SRR (0.71) SRRPSAT1PPARGPPARASLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139264-A1 Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2 WHITEHEAD INST FOR BIOMEDICAL RESEARCH (US) 2026-05-21 US disclosed
US-12385055-B2 Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2 WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2025-08-12 US disclosed
US-20230058465-A1 Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2 WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 2023-02-23 US disclosed
US-11408009-B2 Host cell expression of 4-hydroxyphenylacetaldehyde synthase for production of salidroside, icariside D2, and precursors WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-08-09 US disclosed
US-20190264221-A1 Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2 WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 2019-08-29 US disclosed
CN-102300842-A Radioiodination method 2011-12-28 CN disclosed
US-20050221456-A1 Use of indanoyl amide to stimulate secondary metabolism in Taxus sp. PHYTON BIOTECH, INC. (US) 2005-10-06 US disclosed
CN-1043133-A imidazole-containing peptide and preparation method thereof TANABE SEIYAKU CO (JP) 1990-06-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260139264-A1 Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2 COMT, UGDH, GUSB SRR 911/4885PSAT1 27/4885PPARG 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.